Cargando…
Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation
While there are now fewer allogeneic stem cell transplants (allo-SCT) performed for chronic myeloid leukemia (CML), leukemic relapse post-transplant remains a persistent problem. To better define clinical and biological parameters determining post-relapse outcome, we studied 59 patients with CML rel...
Autores principales: | Jain, Natasha A., Ito, Sawa, Tian, Xin, Kurlander, Roger, Battiwalla, Minoo, Lu, Kit, Savani, Bipin N., Malkovska, Vera, Rezvani, Katayoun, Le, Robert Q, Shenoy, Aarthi, Hourigan, Christopher S., Keyvanfar, Keyvan, Koklanaris, Eleftheria, Superata, Jeanine, Muranski, Pawel, Barrett, A. John, Yong, Agnes S.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318796/ https://www.ncbi.nlm.nih.gov/pubmed/25387087 http://dx.doi.org/10.1038/bmt.2014.249 |
Ejemplares similares
-
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia
por: Jain, Prachi, et al.
Publicado: (2017) -
Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein
por: Yong, Agnes S.M., et al.
Publicado: (2011) -
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
por: Jain, Natasha A., et al.
Publicado: (2020) -
Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival
por: McIver, Zachariah A., et al.
Publicado: (2013) -
Alemtuzumab in T-cell large granular lymphocytic leukaemia: a phase 2 study
por: Dumitriu, Bogdan, et al.
Publicado: (2015)